A patient with cancer has been undergoing chemotherapy and also has risk factors associated with thrombocytopenia. The patient rates her pain as a 5 on a scale of 0 to 10, with 10 being the greatest pain
Which medication would the nurse anticipate being ordered for this patient?
a. Ibuprofen (Motrin)
b. Celecoxib (Celebrex)
c. Acetylsalicylic acid (aspirin)
d. Choline salicylate (Arthropan)
ANS: D
Choline salicylate is indicated for moderate pain; it does not inhibit platelet aggregation and therefore is safe for patients with thrombocytopenia.
Motrin inhibits platelet aggregation and should not be used in patients with thrombocytopenia.
Acetylsalicylic acid should not be used in patients with thrombocytopenia.
Celebrex is not indicated, because it poses a risk of thrombotic events.
You might also like to view...
A client with nausea and vomiting is to receive an antiemetic that inhibits the vomiting center in the brain. Which of the following would the nurse expect the physician to order most likely?
A) Ondansetron (Zofran) B) Hydroxyzine (Vistaril) C) Prochlorperazine (Compazine) D) Promethazine (Phenergan)
The nurse is caring for a 62-year-old African-American woman who has been placed on Coumadin. The nurse should expect the client's response to this medication to be:
a. greater than usual; she may respond exceptionally well to the medication. b. less than usual; she will probably have a decreased therapeutic effect. c. greater than usual; she should be monitored closely for bleeding irregularities. d. less than usual; she will tend to experience a hypersensitivity reaction.
Which is the most commonly reported sexually transmitted infection in young adults in Australia?
a. Chlamydial infections. b. Genital herpes. c. Gonorrhoea. d. Syphilis.
Analyze the major adrenergic effects of the alpha-adrenergic drug class, and select the main drug effect that the alpha-adrenergic drugs have on the alpha-2 receptors.
A. Increased blood pressure B. Contraction of smooth muscle C. Negative feedback effect to decrease the release of epinephrine D. Negative feedback effect to decrease the release of norepinephrine